Cargando…

General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials

OBJECTIVE: This pooled analysis of 3 randomized, placebo‐controlled trials (16–24 week treatment and 8–24 week follow‐up) assessed safety of subcutaneous tanezumab (2.5–10 mg every 8 weeks) in 1,840 patients with hip or knee osteoarthritis. METHODS: Overall treatment‐emergent adverse events (TEAEs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berenbaum, Francis, Schnitzer, Thomas J., Kivitz, Alan J., Viktrup, Lars, Hickman, Anne, Pixton, Glenn, Brown, Mark T., Davignon, Isabelle, West, Christine R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2022
Materias:	Osteoarthritis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310640/ https://www.ncbi.nlm.nih.gov/pubmed/33973384 http://dx.doi.org/10.1002/acr.24637

Ejemplares similares

Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period
por: Berenbaum, Francis, et al.
Publicado: (2020)

Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis
por: Schnitzer, Thomas J., et al.
Publicado: (2021)

Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo‐controlled trials
por: Berenbaum, Francis, et al.
Publicado: (2021)

The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double‐Blind, Placebo‐Controlled, Randomized Clinical Trial
por: Dakin, Paula, et al.
Publicado: (2019)

Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?
por: Berenbaum, Francis, et al.
Publicado: (2021)

Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis
por: Louati, Karine, et al.
Publicado: (2015)

Cartilage-gut-microbiome axis: a new paradigm for novel therapeutic opportunities in osteoarthritis
por: Berthelot, Jean-Marie, et al.
Publicado: (2019)

Association between osteoarthritis and dyslipidaemia: a systematic literature review and meta-analysis
por: Baudart, Pauline, et al.
Publicado: (2017)

Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study
por: Neogi, Tuhina, et al.
Publicado: (2022)

Use of machine learning in osteoarthritis research: a systematic literature review
por: Binvignat, Marie, et al.
Publicado: (2022)

Coronary heart disease is associated with a worse clinical outcome of hand osteoarthritis: a cross-sectional and longitudinal study
por: Courties, Alice, et al.
Publicado: (2017)

Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis
por: Kloppenburg, Margreet, et al.
Publicado: (2019)

Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis
por: Conaghan, Philip G., et al.
Publicado: (2017)

Cardiometabolic risk factors in primary centred and rotator cuff-related shoulder osteoarthritis: a comparative study
por: Juge, Pierre-Antoine, et al.
Publicado: (2017)

Pollutants: a candidate as a new risk factor for osteoarthritis—results from a systematic literature review
por: Deprouw, Camille, et al.
Publicado: (2022)

Development of classification criteria for hand osteoarthritis: comparative analyses of persons with and without hand osteoarthritis
por: Haugen, Ida K, et al.
Publicado: (2020)

Translation of clinical problems in osteoarthritis into pathophysiological research goals
por: van der Kraan, Peter M, et al.
Publicado: (2016)

Neuropathic pain in the IMI-APPROACH knee osteoarthritis cohort: prevalence and phenotyping
por: van Helvoort, Eefje Martine, et al.
Publicado: (2021)

Randomized, Double‐Blind, Placebo‐Controlled Trial of Intraarticular Trans‐Capsaicin for Pain Associated With Osteoarthritis of the Knee
por: Stevens, Randall M., et al.
Publicado: (2019)

Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis
por: Birbara, Charles, et al.
Publicado: (2018)

Pharmacologic Modulation of Hand Pain in Osteoarthritis: A Double-Blind Placebo-Controlled Functional Magnetic Resonance Imaging Study Using Naproxen
por: Sanders, Duncan, et al.
Publicado: (2015)

Development of radiographic classification criteria for hand osteoarthritis: a methodological report (Phase 2)
por: Haugen, Ida K, et al.
Publicado: (2022)

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study—a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
por: Kedor, Claudia, et al.
Publicado: (2021)

Pain in hand osteoarthritis is associated with crystals in the synovial fluid: a cross-sectional study of people with hand osteoarthritis undergoing surgery
por: Døssing, Anna, et al.
Publicado: (2023)

Association between hyperuricaemia and hand osteoarthritis: data from the Xiangya Osteoarthritis Study
por: Zhu, Yanqiu, et al.
Publicado: (2023)

Magnetic Resonance Imaging–Defined Osteoarthritis Features and Anterior Knee Pain in Individuals With, or at Risk for, Knee Osteoarthritis: A Multicenter Study on Osteoarthritis
por: Macri, Erin M., et al.
Publicado: (2022)

Discovery of an autoantibody signature for the early diagnosis of knee osteoarthritis: data from the Osteoarthritis Initiative
por: Camacho-Encina, María, et al.
Publicado: (2019)

Average symptom trajectories following incident radiographic knee osteoarthritis: data from the Osteoarthritis Initiative
por: Whittle, Rebecca, et al.
Publicado: (2016)

Association Between Gut Microbiota and Symptomatic Hand Osteoarthritis: Data From the Xiangya Osteoarthritis Study
por: Wei, Jie, et al.
Publicado: (2021)

Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis
por: Conaghan, Philip G., et al.
Publicado: (2022)

Machine-learning, MRI bone shape and important clinical outcomes in osteoarthritis: data from the Osteoarthritis Initiative
por: Bowes, Michael A., et al.
Publicado: (2021)

Structural Associations of Symptomatic Knee Osteoarthritis
por: Stoppiello, Laura A, et al.
Publicado: (2014)

Obesity, osteoarthritis and genetic risk: The rs182052 polymorphism in the ADIPOQ gene is potentially associated with risk of knee osteoarthritis
por: Jiang, L., et al.
Publicado: (2018)

Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip
por: Tive, Leslie, et al.
Publicado: (2019)

Towards secondary prevention of early knee osteoarthritis
por: Mahmoudian, Armaghan, et al.
Publicado: (2018)

Critical role for arginase II in osteoarthritis pathogenesis
por: Choi, Wan-Su, et al.
Publicado: (2019)

Diabetes mellitus is not a risk factor for osteoarthritis
por: Khor, Andrew, et al.
Publicado: (2020)

Increased risk of osteoarthritis in patients with atopic disease
por: Baker, Matthew C, et al.
Publicado: (2023)

Genome-wide association of phenotypes based on clustering patterns of hand osteoarthritis identify WNT9A as novel osteoarthritis gene
por: Boer, Cindy Germaine, et al.
Publicado: (2021)

The effects of different antihypertensive drugs on pain and joint space width of knee osteoarthritis – A comparative study with data from Osteoarthritis Initiative
por: Li, Mingyang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ttdm4cdgre9g971siht2mlrc5